Literature DB >> 16887985

FcR gamma presence in TCR complex of double-negative T cells is critical for their regulatory function.

Christopher W Thomson1, Wendy A Teft, Wenhao Chen, Boris P-L Lee, Joaquin Madrenas, Li Zhang.   

Abstract

TCRalphabeta+CD4-CD8- double-negative (DN) T regulatory (Treg) cells have recently been shown to suppress Ag-specific immune responses mediated by CD8+ and CD4+ T cells in humans and mice. Our previous study using cDNA microarray analysis of global gene expression showed that FcRgamma was the most highly overexpressed gene in functional DN Treg cell clones compared with nonfunctional mutant clones. In this study, we demonstrate that FcRgamma-deficient DN T cells display markedly reduced suppressive activity in vitro. In addition, unlike FcRgamma-sufficient DN T cells, FcRgamma-deficient DN T cells were unable to prolong donor-specific allograft survival when adoptively transferred to recipient mice. Protein analyses indicate that in addition to FcRgamma, DN Treg cell clones also express higher levels of TCRbeta, while mutant clones expressed higher levels of Zap70 and Lck. Within DN Treg cells, we found that FcRgamma associates with the TCR complex and that both FcRgamma and Syk are phosphorylated in response to TCR cross-linking. Inhibition of Syk signaling and FcRgamma expression were both found to reduce the suppressive function of DN Treg cells in vitro. These results indicate that FcRgamma deficiency significantly impairs the ability of DN Treg cells to down-regulate allogeneic immune responses both in vitro and in vivo, and that FcRgamma plays a role in mediating TCR signaling in DN Treg cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887985     DOI: 10.4049/jimmunol.177.4.2250

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Isolation of double negative αβ T cells from the kidney.

Authors:  Maria N Martina; Samantha Bandapalle; Hamid Rabb; Abdel R Hamad
Journal:  J Vis Exp       Date:  2014-05-16       Impact factor: 1.355

2.  Immune complexes and late complement proteins trigger activation of Syk tyrosine kinase in human CD4(+) T cells.

Authors:  A K Chauhan; T L Moore
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

3.  T cells stimulated with an analog peptide of type II collagen require the Fc receptor γ-chain to secrete interleukin-4 and suppress autoimmune arthritis in mice.

Authors:  Linda K Myers; David L Cullins; David D Brand; Sandra Kleinau; John M Stuart; Andrew H Kang
Journal:  Arthritis Rheum       Date:  2011-09

4.  Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.

Authors:  Sandeep Krishnan; Yuang-Taung Juang; Bhabadeb Chowdhury; Abigail Magilavy; Carolyn U Fisher; Hang Nguyen; Madhusoodana P Nambiar; Vasileios Kyttaris; Arthur Weinstein; Rena Bahjat; Polly Pine; Violeta Rus; George C Tsokos
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

Review 5.  Liver immunology.

Authors:  Dimitrios P Bogdanos; Bin Gao; M Eric Gershwin
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

6.  Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component.

Authors:  Diana Mechtcheriakova; Yury Sobanov; Gabriele Holtappels; Erika Bajna; Martin Svoboda; Markus Jaritz; Claus Bachert; Erika Jensen-Jarolim
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

Review 7.  CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer.

Authors:  Zhiheng Wu; Yu Zheng; Jin Sheng; Yicheng Han; Yanyan Yang; Hongming Pan; Junlin Yao
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

8.  FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.

Authors:  Stephen C Juvet; Christopher W Thomson; Edward Y Kim; Mei Han; Li Zhang
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

9.  Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer.

Authors:  Erin E Hillhouse; Jean-Sébastien Delisle; Sylvie Lesage
Journal:  Front Immunol       Date:  2013-01-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.